Lumira Capital Investment Management Inc. is Director & 10% Owner at Edesa Biotech, Inc. (EDSA). They have made 1 open-market trade across 1 company since 2020, most recently 2024-02-20.
CIK 0001702636
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $862K since 2020, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EDSA | BUY | 2020-01-08 | 2020-01-10 | $3.20 | $862K | -10.7% | -15.2% | -38.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.